Hien N Truong, MD
Pediatric Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 19
- 4 carriers
- Office
- 1
Offices
1 location
Looking this up.
Plans that list them
19 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Truong’s office at (408) 532-0960 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
19 of 19 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
California Medical Board record
Licence A53015 · Current
Licensed to practise in California · since 1994 · expires 2027-08-31 · University of Saigon Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$12,679
Medicare paid this office $12,679 for 50 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 48 | $10,335 | $56 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 13 | $779 | $49 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 11 | $582 | $53 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 11 | $230 | $21 |
Who their Medicare patients are
50 Original Medicare patients in 2024. Average age 71 · Women 56% · Health risk score 0.83. At or below the middle of the specialty; the typical pediatric medicine clinician is at 1.4.
Conditions among them: High blood pressure 70% · Diabetes 40%.
The office billed $36,315, Medicare allowed $23,328 and paid $12,679; for 237 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 50 | 237 | 71 | 0.83 | $36,315 | $12,679 |
| 2023 | 61 | 283 | 71 | 0.88 | $49,600 | $19,477 |
| 2022 | 40 | 180 | 72 | 0.78 | $31,705 | $11,857 |
| 2021 | 38 | 177 | 71 | 0.83 | $30,640 | $10,226 |
| 2020 | 33 | 177 | 70 | 0.93 | $29,405 | $7,025 |
| 2019 | 47 | 219 | 70 | 0.98 | $34,620 | $11,020 |
| 2018 | 47 | 216 | 71 | 1.14 | $36,630 | $10,898 |
| 2017 | 55 | 254 | 68 | 1.06 | $39,575 | $10,829 |
| 2016 | 40 | 241 | 68 | 0.99 | $37,400 | $12,254 |
| 2015 | 46 | 174 | 70 | 1.14 | $29,885 | $8,514 |
| 2014 | 50 | 211 | 67 | 0.74 | $36,675 | $11,797 |
| 2013 | 52 | 258 | 67 | 0.85 | $27,825 | $13,904 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Short return visit (20+ min) | 61 | $19,263 | $69 |
2022: 1 service
| Short return visit (20+ min) | 39 | $11,395 | $64 |
2021: 1 service
| Short return visit (20+ min) | 37 | $9,513 | $56 |
2020: 1 service
| Short return visit (20+ min) | 33 | $6,403 | $40 |
2019: 3 services
| Short return visit (20+ min) | 43 | $9,192 | $52 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 17 | $336 | $19 |
| Administration of influenza virus vaccine | 13 | $267 | $21 |
2018: 1 service
| Short return visit (20+ min) | 42 | $9,824 | $51 |
2017: 3 services
| Short return visit (20+ min) | 50 | $9,229 | $45 |
| Administration of influenza virus vaccine | 18 | $529 | $29 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 19 | $358 | $19 |
2016: 3 services
| Short return visit (20+ min) | 38 | $10,576 | $53 |
| Administration of influenza virus vaccine | 18 | $529 | $29 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 18 | $279 | $15 |
2015: 1 service
| Short return visit (20+ min) | 44 | $7,718 | $48 |
2014: 1 service
| Short return visit (20+ min) | 46 | $11,018 | $55 |
2013: 1 service
| Short return visit (20+ min) | 44 | $12,334 | $54 |
Medicaid work
$19,346 in 2024
Medicaid paid $19,346 for 5,663 billed services this clinician did in 2024, up to 393 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Developmental screening | 292 | $11,309 |
| Short return visit (20+ min) | 4,075 | $3,133 |
| New patient visit (30+ min) | 152 | $2,396 |
| Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use | 24 | $690 |
| Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 305 | $529 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 32 | $470 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 129 | $387 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 109 | $371 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 20 | $60 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 72 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 59 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 51 | $0 |
| 2024 | 5,663 | 15 | 393 | $19,346 |
| 2023 | 11,074 | 21 | 481 | $121,795 |
| 2022 | 10,489 | 26 | 466 | $102,508 |
| 2021 | 11,985 | 28 | 432 | $132,975 |
| 2020 | 12,142 | 33 | 450 | $76,252 |
| 2019 | 17,520 | 35 | 594 | $70,594 |
| 2018 | 11,665 | 25 | 459 | $70,437 |
See the largest Medicaid services in earlier years
2023
| Developmental screening | 1,332 | $65,908 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 422 | $18,508 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 538 | $15,517 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 234 | $6,554 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 69 | $5,575 |
| Short return visit (20+ min) | 6,064 | $3,715 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 50 | $1,853 |
| New patient visit (30+ min) | 190 | $1,576 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 74 | $1,072 |
| Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 546 | $741 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use | 48 | $335 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 43 | $276 |
2022
| Developmental screening | 1,161 | $50,849 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 533 | $16,242 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 372 | $13,299 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 98 | $5,693 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 212 | $4,452 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 228 | $2,569 |
| Short return visit (20+ min) | 5,697 | $2,293 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 87 | $1,700 |
| New patient visit (30+ min) | 194 | $1,520 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 19 | $1,414 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; adolescent (age 12 through 17 years) | 15 | $653 |
| Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 651 | $365 |
2021
| Developmental screening | 1,247 | $59,999 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 562 | $17,789 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 384 | $15,113 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 84 | $7,624 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 253 | $6,931 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 527 | $6,121 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 270 | $5,482 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 209 | $4,191 |
| Screening test, pure tone, air only | 645 | $3,508 |
| Short return visit (20+ min) | 4,837 | $2,207 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 99 | $850 |
| Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use | 54 | $597 |
2020
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 583 | $17,608 |
| Developmental screening | 355 | $14,610 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 495 | $12,470 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 515 | $6,441 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 364 | $6,134 |
| Pure tone audiometry (threshold); air only | 456 | $5,832 |
| Screening test, pure tone, air only | 903 | $2,837 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 324 | $2,109 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 50 | $1,901 |
| Short return visit (20+ min) | 4,550 | $1,422 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 140 | $1,389 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 70 | $1,142 |
2019
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 548 | $14,714 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 746 | $14,371 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 552 | $10,256 |
| Pure tone audiometry (threshold); air only | 678 | $8,672 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 275 | $3,608 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 358 | $3,551 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 181 | $3,541 |
| New patient visit (30+ min) | 244 | $3,289 |
| Short return visit (20+ min) | 7,076 | $3,180 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 177 | $910 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 100 | $823 |
| Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use | 173 | $791 |
2018
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 528 | $15,029 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 413 | $13,827 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 368 | $9,173 |
| Pure tone audiometry (threshold); air only | 759 | $9,158 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 469 | $4,713 |
| Short return visit (20+ min) | 5,552 | $3,632 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 172 | $3,431 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 349 | $3,409 |
| New patient visit (30+ min) | 98 | $2,990 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 160 | $1,815 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 99 | $695 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 94 | $649 |
Drugs they prescribed that Part D paid
$60,093
Pharmacies billed $60,093 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,018) in 2024. At or below the middle of the specialty; the typical pediatric medicine clinician is at 0%.
1,844 generic and fewer than 11 brand-name prescriptions · $60,093 in drug cost · 295 antibiotic prescriptions to 99 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vascepa | 12 | $4,831 | $403 |
| Albuterol Sulfate Hfa | 54 | $1,779 | $33 |
| Metformin | 94 | $1,173 | $12 |
| Cephalexin | 112 | $889 | $8 |
| Triamcinolone Acetonide | 129 | $815 | $6 |
See all 38 drugs
| Vascepa | 12 | $4,831 | $403 |
| Albuterol Sulfate Hfa | 54 | $1,779 | $33 |
| Metformin | 94 | $1,173 | $12 |
| Cephalexin | 112 | $889 | $8 |
| Triamcinolone Acetonide | 129 | $815 | $6 |
| Rifampin | 21 | $646 | $31 |
| Omeprazole | 114 | $621 | $5 |
| Fluocinonide | 17 | $598 | $35 |
| Lovastatin | 105 | $593 | $6 |
| Ketoconazole | 21 | $456 | $22 |
| Benazepril | 73 | $427 | $6 |
| Gabapentin | 31 | $344 | $11 |
| Baclofen | 15 | $335 | $22 |
| Azelastine | 50 | $330 | $7 |
| Atorvastatin | 68 | $324 | $5 |
| Fluticasone Propionate | 46 | $298 | $6 |
| Ciprofloxacin | 24 | $284 | $12 |
| Propranolol | 17 | $266 | $16 |
| Ibuprofen | 91 | $256 | $3 |
| Losartan | 52 | $209 | $4 |
| Amoxicillin | 70 | $169 | $2 |
| Azithromycin | 91 | $165 | $2 |
| Acyclovir | 11 | $141 | $13 |
| Tamsulosin | 15 | $132 | $9 |
| Alendronate | 36 | $131 | $4 |
| Meclizine | 21 | $123 | $6 |
| Rosuvastatin | 17 | $115 | $7 |
| Hydrochlorothiazide | 36 | $104 | $3 |
| Amlodipine Besylate | 81 | $93 | $1 |
| Clopidogrel | 21 | $82 | $4 |
| Lisinopril | 21 | $76 | $4 |
| Glyburide | 11 | $44 | $4 |
| Glipizide | 13 | $42 | $3 |
| Metoprolol | 16 | $37 | $2 |
| Atenolol | 11 | $36 | $3 |
| Promethazine | 14 | $32 | $2 |
| Furosemide | 17 | $26 | $2 |
| Prednisone | 14 | $17 | $1 |
Year by year
| 2024 | 2,018 | 141 | 0% (0) | None | $60,093 |
| 2023 | 1,473 | 116 | None | 10% | $96,868 |
| 2022 | 1,140 | 93 | None | 9% | $51,778 |
| 2021 | 934 | 85 | None | None | $43,019 |
| 2020 | 879 | 74 | None | 9% | $38,367 |
| 2019 | 917 | 77 | None | None | $29,396 |
| 2018 | 836 | 78 | None | 8% | $33,251 |
| 2017 | 775 | 77 | 1% (11) | None | $24,859 |
| 2016 | 696 | 61 | None | None | $22,908 |
| 2015 | 717 | 63 | None | None | $26,041 |
| 2014 | 658 | 61 | None | None | $20,142 |
| 2013 | 747 | 65 | None | None | $27,086 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 29 drugs
| Metformin | 51 | $2,011 | $39 |
| Omeprazole | 98 | $1,866 | $19 |
| Lovastatin | 73 | $1,514 | $21 |
| Albuterol Sulfate Hfa | 33 | $1,306 | $40 |
| Cephalexin | 74 | $1,298 | $18 |
| Amlodipine Besylate | 51 | $1,233 | $24 |
| Triamcinolone Acetonide | 96 | $1,185 | $12 |
| Benazepril | 50 | $986 | $20 |
| Alendronate | 31 | $965 | $31 |
| Atorvastatin | 40 | $939 | $23 |
| Azelastine | 32 | $832 | $26 |
| Ibuprofen | 92 | $732 | $8 |
| Rifampin | 16 | $732 | $46 |
| Losartan | 31 | $649 | $21 |
| Gabapentin | 21 | $558 | $27 |
| Ketoconazole | 17 | $428 | $25 |
| Fluticasone Propionate | 36 | $428 | $12 |
| Rosuvastatin | 15 | $404 | $27 |
| Amoxicillin | 57 | $344 | $6 |
| Lisinopril | 12 | $335 | $28 |
| Azithromycin | 53 | $281 | $5 |
| Hydrochlorothiazide | 38 | $256 | $7 |
| Meclizine | 30 | $253 | $8 |
| Atenolol | 12 | $200 | $17 |
| Ciprofloxacin | 12 | $194 | $16 |
| Metoprolol | 12 | $192 | $16 |
| Furosemide | 11 | $70 | $6 |
| Prednisone | 18 | $48 | $3 |
| Promethazine | 14 | $47 | $3 |
2022: 27 drugs
| Shingrix | 12 | $2,288 | $191 |
| Vascepa | 16 | $1,969 | $123 |
| Azelastine | 28 | $1,024 | $37 |
| Lovastatin | 56 | $927 | $17 |
| Omeprazole | 79 | $877 | $11 |
| Triamcinolone Acetonide | 63 | $786 | $12 |
| Benazepril | 46 | $652 | $14 |
| Atorvastatin | 32 | $620 | $19 |
| Cephalexin | 61 | $619 | $10 |
| Lactulose | 16 | $606 | $38 |
| Albuterol Sulfate Hfa | 12 | $519 | $43 |
| Amoxicillin | 69 | $400 | $6 |
| Hydrocortisone | 11 | $394 | $36 |
| Alendronate | 24 | $376 | $16 |
| Losartan | 19 | $354 | $19 |
| Metformin | 36 | $348 | $10 |
| Ibuprofen | 65 | $335 | $5 |
| Fluticasone Propionate | 31 | $321 | $10 |
| Azithromycin | 51 | $299 | $6 |
| Amlodipine Besylate | 32 | $259 | $8 |
| Hydrochlorothiazide | 38 | $217 | $6 |
| Gabapentin | 11 | $210 | $19 |
| Glyburide | 11 | $158 | $14 |
| Atenolol | 13 | $148 | $11 |
| Furosemide | 20 | $110 | $5 |
| Meclizine | 13 | $90 | $7 |
| Promethazine | 11 | $61 | $6 |
2021: 22 drugs
| Vascepa | 15 | $2,014 | $134 |
| Triamcinolone Acetonide | 65 | $854 | $13 |
| Lactulose | 20 | $851 | $43 |
| Azelastine | 21 | $710 | $34 |
| Omeprazole | 68 | $677 | $10 |
| Atorvastatin | 33 | $620 | $19 |
| Cephalexin | 55 | $547 | $10 |
| Amoxicillin | 64 | $401 | $6 |
| Lovastatin | 32 | $362 | $11 |
| Fluticasone Propionate | 30 | $322 | $11 |
| Benazepril | 41 | $313 | $8 |
| Amlodipine Besylate | 33 | $292 | $9 |
| Ibuprofen | 52 | $255 | $5 |
| Alendronate | 20 | $229 | $11 |
| Lisinopril | 13 | $176 | $14 |
| Hydrochlorothiazide | 24 | $160 | $7 |
| Losartan | 11 | $152 | $14 |
| Metformin | 21 | $151 | $7 |
| Meclizine | 20 | $144 | $7 |
| Azithromycin | 16 | $133 | $8 |
| Tamsulosin | 12 | $124 | $10 |
| Promethazine | 11 | $74 | $7 |
2020: 23 drugs
| Shingrix | 12 | $2,072 | $173 |
| Alcohol Pads | 17 | $1,478 | $87 |
| Vascepa | 11 | $949 | $86 |
| Azelastine | 23 | $886 | $39 |
| Triamcinolone Acetonide | 50 | $628 | $13 |
| Lactulose | 19 | $491 | $26 |
| Atorvastatin | 31 | $370 | $12 |
| Cephalexin | 43 | $330 | $8 |
| Ibuprofen | 60 | $313 | $5 |
| Omeprazole | 55 | $285 | $5 |
| Glyburide | 11 | $272 | $25 |
| Benazepril | 33 | $234 | $7 |
| Lovastatin | 26 | $228 | $9 |
| Amoxicillin | 52 | $217 | $4 |
| Fluticasone Propionate | 15 | $195 | $13 |
| Amlodipine Besylate | 28 | $161 | $6 |
| Hydrochlorothiazide | 21 | $144 | $7 |
| Azithromycin | 27 | $129 | $5 |
| Metformin | 23 | $115 | $5 |
| Alendronate | 16 | $113 | $7 |
| Meclizine | 14 | $105 | $7 |
| Ciprofloxacin | 11 | $102 | $9 |
| Furosemide | 11 | $27 | $2 |
2019: 22 drugs
| Shingrix | 11 | $1,872 | $170 |
| Triamcinolone Acetonide | 72 | $890 | $12 |
| Cephalexin | 50 | $515 | $10 |
| Azelastine | 13 | $421 | $32 |
| Omeprazole | 52 | $377 | $7 |
| Atorvastatin | 28 | $360 | $13 |
| Azithromycin | 46 | $322 | $7 |
| Ibuprofen | 54 | $295 | $5 |
| Lovastatin | 31 | $275 | $9 |
| Amoxicillin | 45 | $251 | $6 |
| Benazepril | 46 | $249 | $5 |
| Cromolyn | 17 | $248 | $15 |
| Fluticasone Propionate | 16 | $216 | $14 |
| Amlodipine Besylate | 30 | $183 | $6 |
| Alendronate | 20 | $177 | $9 |
| Ranitidine | 26 | $161 | $6 |
| Metformin | 19 | $118 | $6 |
| Atenolol | 11 | $110 | $10 |
| Simvastatin | 16 | $98 | $6 |
| Glyburide | 13 | $95 | $7 |
| Hydrochlorothiazide | 15 | $71 | $5 |
| Glipizide | 14 | $57 | $4 |
2018: 17 drugs
| Triamcinolone Acetonide | 67 | $807 | $12 |
| Lovastatin | 26 | $458 | $18 |
| Cephalexin | 45 | $449 | $10 |
| Ibuprofen | 58 | $325 | $6 |
| Benazepril | 32 | $296 | $9 |
| Azithromycin | 44 | $245 | $6 |
| Ranitidine | 33 | $226 | $7 |
| Amoxicillin | 36 | $201 | $6 |
| Fluticasone Propionate | 19 | $201 | $11 |
| Omeprazole | 30 | $200 | $7 |
| Alendronate | 22 | $198 | $9 |
| Cromolyn | 19 | $177 | $9 |
| Amlodipine Besylate | 31 | $168 | $5 |
| Metformin | 20 | $135 | $7 |
| Simvastatin | 24 | $94 | $4 |
| Hydrochlorothiazide | 13 | $65 | $5 |
| Glipizide | 18 | $60 | $3 |
2017: 21 drugs
| Triamcinolone Acetonide | 50 | $542 | $11 |
| Lovastatin | 26 | $407 | $16 |
| Ranitidine | 28 | $384 | $14 |
| Cephalexin | 44 | $373 | $8 |
| Benazepril | 30 | $300 | $10 |
| Tamsulosin | 11 | $245 | $22 |
| Amoxicillin | 47 | $231 | $5 |
| Diphenoxylate-Atropine | 13 | $226 | $17 |
| Alendronate | 20 | $212 | $11 |
| Ibuprofen | 41 | $210 | $5 |
| Metformin | 27 | $210 | $8 |
| Levothyroxine | 13 | $195 | $15 |
| Fosinopril | 13 | $186 | $14 |
| Azithromycin | 41 | $184 | $4 |
| Fluticasone Propionate | 16 | $171 | $11 |
| Atorvastatin | 12 | $169 | $14 |
| Cromolyn | 16 | $148 | $9 |
| Amlodipine Besylate | 16 | $106 | $7 |
| Glipizide | 21 | $96 | $5 |
| Omeprazole | 24 | $92 | $4 |
| Simvastatin | 14 | $75 | $5 |
2016: 17 drugs
| Triamcinolone Acetonide | 38 | $543 | $14 |
| Tamsulosin | 13 | $397 | $31 |
| Ranitidine | 27 | $302 | $11 |
| Fosinopril | 12 | $290 | $24 |
| Lovastatin | 19 | $251 | $13 |
| Metformin | 24 | $243 | $10 |
| Cephalexin | 35 | $225 | $6 |
| Alendronate | 33 | $213 | $6 |
| Amoxicillin | 44 | $193 | $4 |
| Ibuprofen | 33 | $150 | $5 |
| Atenolol | 17 | $149 | $9 |
| Benazepril | 18 | $148 | $8 |
| Azithromycin | 26 | $147 | $6 |
| Simvastatin | 20 | $139 | $7 |
| Cromolyn | 15 | $137 | $9 |
| Amlodipine Besylate | 26 | $129 | $5 |
| Glipizide | 23 | $122 | $5 |
2015: 21 drugs
| Fluocinonide | 13 | $1,509 | $116 |
| Triamcinolone Acetonide | 50 | $738 | $15 |
| Tamsulosin | 18 | $498 | $28 |
| Amlodipine Besylate-Benazepril | 11 | $395 | $36 |
| Alendronate | 29 | $285 | $10 |
| Ranitidine | 17 | $268 | $16 |
| Lovastatin | 26 | $239 | $9 |
| Amoxicillin | 49 | $230 | $5 |
| Metformin | 38 | $190 | $5 |
| Amlodipine Besylate | 36 | $181 | $5 |
| Cephalexin | 26 | $177 | $7 |
| Ibuprofen | 39 | $167 | $4 |
| Omeprazole | 19 | $151 | $8 |
| Benazepril | 27 | $143 | $5 |
| Azithromycin | 18 | $125 | $7 |
| Cromolyn | 12 | $123 | $10 |
| Fluticasone Propionate | 12 | $116 | $10 |
| Diphenoxylate-Atropine | 11 | $114 | $10 |
| Simvastatin | 26 | $98 | $4 |
| Glipizide | 22 | $81 | $4 |
| Hydrochlorothiazide | 11 | $48 | $4 |
2014: 19 drugs
| Restasis | 14 | $3,751 | $268 |
| Lidoderm | 11 | $2,932 | $267 |
| Diovan | 12 | $2,168 | $181 |
| Triamcinolone Acetonide | 39 | $726 | $19 |
| Metformin | 45 | $335 | $7 |
| Benazepril | 49 | $318 | $6 |
| Simvastatin | 43 | $309 | $7 |
| Lovastatin | 26 | $268 | $10 |
| Amoxicillin | 42 | $265 | $6 |
| Cephalexin | 24 | $240 | $10 |
| Amlodipine Besylate-Benazepril | 12 | $236 | $20 |
| Alendronate | 20 | $236 | $12 |
| Atorvastatin | 15 | $150 | $10 |
| Ranitidine | 14 | $147 | $10 |
| Ibuprofen | 26 | $128 | $5 |
| Amlodipine Besylate | 26 | $101 | $4 |
| Glipizide | 23 | $93 | $4 |
| Azithromycin | 11 | $80 | $7 |
| Atenolol | 12 | $40 | $3 |
2013: 21 drugs
| Qvar | 12 | $1,937 | $161 |
| Diovan | 11 | $1,912 | $174 |
| Amlodipine Besylate-Benazepril | 20 | $878 | $44 |
| Fluticasone Propionate | 20 | $540 | $27 |
| Triamcinolone Acetonide | 28 | $514 | $18 |
| Metformin | 53 | $454 | $9 |
| Simvastatin | 50 | $422 | $8 |
| Amoxicillin | 58 | $367 | $6 |
| Benazepril | 41 | $269 | $7 |
| Omeprazole | 21 | $233 | $11 |
| Lovastatin | 11 | $188 | $17 |
| Cephalexin | 17 | $179 | $11 |
| Amlodipine Besylate | 29 | $172 | $6 |
| Ranitidine | 15 | $151 | $10 |
| Gabapentin | 15 | $148 | $10 |
| Ibuprofen | 34 | $147 | $4 |
| Glipizide | 22 | $127 | $6 |
| Cromolyn | 11 | $116 | $11 |
| Atenolol | 27 | $111 | $4 |
| Glimepiride | 15 | $87 | $6 |
| Hydrochlorothiazide | 17 | $76 | $4 |
Money from drug and device companies
$308 in 2025
| 2025 | 2 | 12 | None | $308 |
| 2024 | 1 | 1 | None | $23 |
| 2022 | 2 | 2 | None | $241 |
| 2021 | 1 | 1 | None | $113 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Kowa Pharmaceuticals America | Zoryve | $186 | 11 payments
|
| GlaxoSmithKline | Penmenvy | $122 | 1 payment
|
See all 12 published payments
| Kowa Pharmaceuticals America | Meals · 2025-12-11 | Zoryve | $23 |
| Kowa Pharmaceuticals America | Meals · 2025-10-30 | Zoryve | $23 |
| Kowa Pharmaceuticals America | Meals · 2025-10-02 | Zoryve | $20 |
| Kowa Pharmaceuticals America | Meals · 2025-09-18 | Zoryve | $20 |
| GlaxoSmithKline | Meals · 2025-09-16 | Penmenvy | $122 |
| Kowa Pharmaceuticals America | Meals · 2025-08-21 | Zoryve | $12 |
| Kowa Pharmaceuticals America | Meals · 2025-07-31 | Zoryve | $15 |
| Kowa Pharmaceuticals America | Meals · 2025-07-17 | Zoryve | $22 |
| Kowa Pharmaceuticals America | Meals · 2025-06-23 | Zoryve | $18 |
| Kowa Pharmaceuticals America | Meals · 2025-06-05 | Zoryve | $9 |
| Kowa Pharmaceuticals America | Meals · 2025-05-19 | Zoryve | $16 |
| Kowa Pharmaceuticals America | Meals · 2025-01-06 | Zoryve | $8 |
See earlier years (2024, 2022, 2021)
2024: $23
| Pfizer | Prevnar 20 | $23 | 1 payment
|
2022: $241
| AstraZeneca Pharmaceuticals LP | Farxiga | $125 | 1 payment
|
| Urovant Sciences | Gemtesa | $116 | 1 payment
|
2021: $113
| Novo Nordisk | Rybelsus | $113 | 1 payment
|
Professional record
- NPI
- 1235150822
- Licence
- CA A53015California A53015: Current · expires 2027-08-31
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 2593 S. King Road Suite 4, San Jose, CA, 95122
- NPI first listed
- 2006-07-21
- NPI last updated
- 2010-08-30
This is when the NPI record was last certified, not a medical board exam.